A stronger weight loss shot added little extra loss but more stomach upset

Turning up the amount of a medicine often seems like the obvious way to get more from it. A large trial of a weekly weight loss shot suggests that is not always true. Going from a smaller amount to a bigger one barely changed how much weight people lost [1].

After 76 weeks, about a year and a half, adults on the smaller amount had lost 12.2 percent of their body weight on average. That is about an eighth. On the bigger amount, they lost 13.0 percent. People given a placebo, a look alike shot with no medicine in it, lost 5.4 percent [1].

The main caveat is simple. The shot was compared only with the placebo, never with another weight loss medicine, so this trial cannot say how it ranks against shots already in use [1].

The shot is called survodutide. The trial, named SYNCHRONIZE-1, was led by Carel le Roux of the University College Dublin School of Medicine. It was published in the New England Journal of Medicine in 2026. The drug company Boehringer Ingelheim paid for it, and several authors work there [1].

Like the best known weight loss shots, this one switches on the GLP-1 receptor, a kind of switch on cells that answers to a gut hormone. It also switches on a second one, the glucagon receptor, which scientists study for its part in how the body uses energy [1].

Who was in the trial?

The trial took in 725 adults with obesity, or extra weight plus a related health problem, and none had diabetes. Their average age was 47, and they weighed about 109 kilograms on average at the start. Chance, like a coin flip, put them into three groups of about 240 people each. Everyone also got coaching on eating and staying active [1][2].

About 7 in 10 people on either amount lost at least 5 percent of their weight. On the placebo, it was a little under half. The fake shot group did unusually well, which leaves less room for the drug to stand out. The researchers concluded:

Survodutide led to significantly greater reductions in body weight than placebo in adults with obesity without diabetes.

le Roux and colleagues, New England Journal of Medicine, 2026 [1]

In plain words, the shot beat the fake shot. The cost showed up in side effects. Stomach and gut problems, such as feeling sick, throwing up and loose stools, were common. They hit about 8 in 10 people on the smaller amount and about 9 in 10 on the bigger one. On the placebo, it was about half. Most cases were mild to moderate, and no deaths were reported [1].

Why did the company announce a bigger number?

Months before the journal paper, Zealand Pharma, the company that discovered the drug, announced weight loss of up to 16.6 percent, against 3.2 percent on placebo. That number counts people only while they were really taking the shot. The journal number keeps everyone in the group chance put them in, even people who stopped early. The trial chose this stricter count as its main one before it began [1][4].

Both counts describe the same 725 people, and neither is wrong. The first asks what the medicine does when people take it. The second asks what happens to a whole group that starts on it. A reader who sees only one number gets half the picture [1][4].

A second late stage trial, published in Nature Medicine, tested the bigger amount for 48 weeks in 216 adults with obesity and fatty liver disease. On a scan, about 7 in 10 people on the drug cut their liver fat by at least 30 percent, by the stricter count. On the placebo, it was nearly 3 in 10. Its authors named their own limits:

Limitations included short trial duration (48 weeks) and limited global reach (participants recruited in the United States and Spain).

Kaplan and colleagues, Nature Medicine, 2026 [3]

In plain words, the trial was short and drew people from only two countries. Liver fat on a scan is also a measurement, not a health outcome such as liver failure [3].

The registry shows the main trial started in November 2023 and collected its main result in December 2025, so a third year was never measured [2]. This trial does not show how the shot compares with other medicines, or what happens after people stop. What it does show is that both amounts led to clearly more weight loss than a fake shot, and the bigger amount added little except side effects [1].